Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 54: 858-865, 2008. First published March 13, 2008; 10.1373/clinchem.2007.090266
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
clinchem.2007.090266v1
54/5/858    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hammerer-Lercher, A.
Right arrow Articles by Lindner, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hammerer-Lercher, A.
Right arrow Articles by Lindner, H. H.
Related Collections
Right arrow Proteomics and Protein Markers
(Clinical Chemistry. 2008;54:858-865.)
© 2008 American Association for Clinical Chemistry, Inc.

Proteomics and Protein Markers

Analysis of Circulating Forms of proBNP and NT-proBNP in Patients with Severe Heart Failure

Angelika Hammerer-Lercher1,2,2, Bernhard Halfinger1,2, Bettina Sarg1, Johannes Mair3, Bernd Puschendorf1,3, Andrea Griesmacher2, Norberto A. Guzman1 and Herbert H. Lindner1,a

1 Division of Clinical Biochemistry, Innsbruck Biocenter, Innsbruck Medical University, Innsbruck, Austria; 2 Department of Medical and Chemical Laboratory Diagnostics, Innsbruck Medical University, Innsbruck, Austria; 3 Department of Internal Medicine, Clinical Division of Cardiology, Innsbruck Medical University, Innsbruck, Austria.

aAddress correspondence to this author at: Division of Clinical Biochemistry, Innsbruck, Biocenter, Innsbruck Medical University, Fritz-Pregl-Str. 3, A-6020 Innsbruck, Austria. Fax 43-512-9003-73300; e-mail herbert.lindner{at}i-med.ac.at.

Background: The specific forms of pro–B-type natriuretic peptide (proBNP) that occur in human blood are not yet clear. We demonstrated the presence of several proBNP forms in human plasma with a new affinity chromatography method that can be used in combination with nano–liquid chromatography electrospray ionization tandem mass spectrometry (nano-LC–ESI–MS/MS).

Methods: For affinity chromatography, we coupled Fab' fragments of polyclonal sheep antibodies specific for N-terminal proBNP (NT-proBNP) epitope 1–21 to silica beads. We connected a column (10 mm x 0.8 mm inner diameter) packed with these beads to a trypsin reactor and used a preconcentrator in combination with a fritless nanospray column to perform MS analyses of proBNP forms in preextracted and non-preextracted samples of plasma from patients with severe heart failure (HF). We used Western blotting in deglycosylation experiments to confirm the shifts in proBNP and NT-proBNP masses.

Results: Tandem MS experiments demonstrated the presence of both NT-proBNP and circulating proBNP in preextracted samples of plasma from patients with severe HF, and Western blotting analyses revealed 2 bands of approximately 23 kDa and 13 kDa that shifted after deglycosylation to positions that corresponded to the locations of recombinant proBNP and synthetic NT-proBNP.

Conclusions: We obtained clear evidence for circulating proBNP in patients with severe HF and provided the first demonstration of O-glycosylation of NT-proBNP. The higher molecular masses for NT-proBNP and proBNP observed in the Western blotting analyses than those expected from calculations can be explained by O-glycosylation of these peptides in vivo.




The following articles in journals at HighWire Press have cited this article:


Home page
 HeartHome page
M Schou, U Alehagen, J P Goetze, F Gustafsson, and U Dahlstrom
Effect of estimated glomerular filtration rate on plasma concentrations of B-type natriuretic peptides measured with multiple immunoassays in elderly individuals
Heart, September 15, 2009; 95(18): 1514 - 1519.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. Mair
Clinical Significance of Pro-B-Type Natriuretic Peptide Glycosylation and Processing
Clin. Chem., March 1, 2009; 55(3): 394 - 397.
[Full Text] [PDF]

Home page
 Eur Heart JHome page
L. Frankenstein, A. Remppis, M. Nelles, B. Schaelling, D. Schellberg, H. Katus, and C. Zugck
Relation of N-terminal pro-brain natriuretic peptide levels and their prognostic power in chronic stable heart failure to obesity status
Eur. Heart J., November 1, 2008; 29(21): 2634 - 2640.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Association for Clinical Chemistry.